Targeted Introduction of Substances into the Lymph Nodes for Endolymphatic Therapy

  • Peter Hirnle
Part of the Cancer Treatment and Research book series (CTAR, volume 135)

Lymph node metastases are an important prognostic factor in cancer, irrespective of where the tumour is located. Until today, treatment by surgery or irradiation may be associated with massive side effects so that efficient and safe alternatives are still required. Radical surgery to treat or prevent progressing disease usually involves the removal of the regional lymph nodes, but also of their surrounding tissue and of lymph vessels. The destruction of the adjacent structures is aggravated by the problem of discerning lymph nodes from their surrounding fatty tissue.This poor selectivity leads not only to side effects, such as secondary lymphedema, but also bears the danger to overlook lymph nodes, which increases the risk of nodal recurrence. The dimension of the problem could be demonstrated by post-operative lymphangiograms, depicting the remaining lymph nodes after radical surgery (28).


Lymph Node Sentinel Lymph Node Lymph System Retroperitoneal Lymph Node Cytostatic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ansick, A.C., Sie Go, D., van der Velden, J. et al: Identification of sentinel lymph node in vulvar carcinoma patients with the aid of a patent blue V injection: A multicenter study. Cancer 86 (1999), 652-656CrossRefGoogle Scholar
  2. 2.
    Bland, K.I.: Refining the optimal technical approach for sentinel node localization in breast cancer patients. Ann. Surg. Oncol.6 (1999), 418-419PubMedCrossRefGoogle Scholar
  3. 3.
    Bostic, P.J., Giuliano, A.E.: Vital dyes in sentinel node localization. Sem.Nucl. Med. 30 (2000), 18-24CrossRefGoogle Scholar
  4. 4.
    Broughton, A., Strong, J.E.: Radioimmunoassay of Bleomycin. Cancer Research 36 (1976), 1418PubMedGoogle Scholar
  5. 5.
    Dieter, M., Schubert, R., Hirnle, P.: Blue liposomes for identification of the sentinel lymph nodes in pigs. Lymphology 36 (2003), 39-47PubMedGoogle Scholar
  6. 6.
    Dietschy, J.M., Siperstein, M.D.: Cholesterol synthesis by the gastrointestinal tract: localisation and mechanisms of control. Journal of Clinical Investigation 44 (1965), 1311PubMedCrossRefGoogle Scholar
  7. 7.
    Gallegos Hernanadez, J.F., Gutierrez, F., Barosso, S. et al: Identification of sentinel lymph node with patent blue V in patients with cutaneous melanoma. Gac. Med. Mex. 134 (1998), 419-422Google Scholar
  8. 8.
    Gennari, R., Soldt, H.S., Bartolomei, M. et al: Sentinel node localization: A new prospective in the treatment of nodal melanoma metastases. Intl. J. Oncol. 15 (1999), 25-32Google Scholar
  9. 9.
    Haigh, P.I., Giuliano, A.E.: Role of sentinel lymph node dissection in breast cancer. Annals of medicine 32 (2000), 51-56PubMedCrossRefGoogle Scholar
  10. 10.
    Harzmann, R., Hirnle P., Geppert, M.: Retroperitoneal lymph nodal visualization using 20 % Guajazulen blue (chromolymphography). Lymphology 22 (1989),147-149PubMedGoogle Scholar
  11. 11.
    Hirnle, P.: Endolymphatic application of Bleomycin oil suspension in dog model. Lymphology 18 (1985), 56-63PubMedGoogle Scholar
  12. 12.
    Hirnle, P.: Histological findings in rabbit lymph nodes after endolymphatic injection of liposomes containing blue dye. J. Pharm. Pharmacol. 43 (1991), 217-218PubMedGoogle Scholar
  13. 13.
    Hirnle, P., Geppert, M.: Histologic changes in dog lymph nodes after endolymphatic application of bleomycin oil suspension. Lymphology 22 (1989), 100-102PubMedGoogle Scholar
  14. 14.
    Hirnle, P., Harzmann, R., Wright, J.K.: Patent blue V encapsulation in liposomes: potential applicability to endolymphatic therapy and preoperative chromolymphography. Lymphology 21 (1988), 187-189PubMedGoogle Scholar
  15. 15.
    Hirnle, P., Heide, P.E.: Iodinated emulsions of cytostatic agents for combined diagnostic and therapeutic lymphography. In: Casley-Smith, J.R., Piller, N.B. (eds.) Progress in Lymphology, University of Adelaide Press (1985), 279-281Google Scholar
  16. 16.
    Hirnle, P., Jaroni, H., Schmidt, K.-H.: Endolymphatic application of liposomes containing bleomycin in rabbits. In: Casley-Smith, J.R., Piller, N.B. (eds.) Progress in Lymphology, University of Adelaide Press (1986), 276-278Google Scholar
  17. 17.
    Hirnle, P., Schubert R.: Liposomes containing blue dye for preoperative lymph node staining: Distribution and stability in dogs after endolymphatic injection. Int J Pharmaceutics 72 (1991), 259-269CrossRefGoogle Scholar
  18. 18.
    Hwang, K.J., Mauk, M.R.: Fate of lipid vesicles in vivo: A gamma-ray perturbed angular correlation study. Proceedings of the National Academy of Sciences (USA) 74 (1977), 4991CrossRefGoogle Scholar
  19. 19.
    Joosten, J.A.A., Stroble, L.J.A., Wauters, C.A.P. et al: Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. British J. Surgery: 86 (1999), 482-488CrossRefGoogle Scholar
  20. 20.
    Kern, K.A.: Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J. Am. Coll. Surg. 189 (1999), 539-545PubMedCrossRefGoogle Scholar
  21. 21.
    Kinmonth, J.B.: The lymphatics. Surgery, lymphography and disease of the chyle and lymph system. Edward Arnold 1982Google Scholar
  22. 22.
    Lucci, A., Turner, R.R., Morton, D.L.: Carbon dye as an adjunct to isosulfan blue dye for sentinel lymph node dissection. Surgery 126 (1999), 48-53PubMedCrossRefGoogle Scholar
  23. 23.
    Mathew, C.P., Intralymphatic chemotherapy. Case report of a successful result. Indian J. Cancer, 6, 112, 1969PubMedGoogle Scholar
  24. 24.
    Milsman, H.W., Schwenderer, R.A., Weder, H.G.: The preparation of large single bilayer liposomes by a fast and controlled dialysis. Biochemica et Biophysica Acta 512 (1978), 147CrossRefGoogle Scholar
  25. 25.
    Nickel, R., Schummer, A., Seiferle, E.: Lehrbuch der Anatomie der Haustiere. Parey, Berlin, Hamburg (1976)Google Scholar
  26. 26.
    Patterson, R.M., Ballard, C.L., Wasserman, K., Mayerson, H.S.: Lymphatic permeability to albumin. American Journal of Physiology 194 (1958), 120PubMedGoogle Scholar
  27. 27.
    Pinter, G.G., Zilversmith, D.B.: A gradient centrifugation method for the determination of particle size distribution of chylomicrons and of fat droplets in artificial fat emulsion. Biochemica et Biophysica Acta 59 (1962),116CrossRefGoogle Scholar
  28. 28.
    Piver, M.S., Wallace, S., Castro, J.R.: The accuracy of lymphangiography in carcinoma of the uterine cervix. American Journal of Roentgenology 111 (1971), 278Google Scholar
  29. 29.
    Redgrave, T.G., Dunne, K.B.: Chylomicron formation and composition in unanaesthetized rabbits. Atherosclerosis 22 (1975), 389PubMedCrossRefGoogle Scholar
  30. 30.
    Roumen, R.M., Geuskens, L.M., Valkenburg, J.G.: In search of the true sentinel node by different injection techniques in breast cancer patients. Eur. J. Surg. Oncol. 25 (1999), 347-351PubMedCrossRefGoogle Scholar
  31. 31.
    Rozenberg, S, Liebens, F., Ham, H.: False-negative rates in sentinel node in breast cancer. Lancet 354 (1999), 773-774CrossRefGoogle Scholar
  32. 32.
    Scow, R.O., Stein, Y., Stein, O.: Incorporation of dietary lecithin and lysolecithin into lymph chylomicrons in the rat. Journal of Biological Chemistry 242 (1967), 4919PubMedGoogle Scholar
  33. 33.
    Wallace, A.M., Vera, D.R., Stadalnik, R.C.: Blue dye and Tc-99m-labeled human serum albumin: Sentinel node detection by magic bullets? J. Nucl. Med. 40 (1999), 1149-1150.PubMedGoogle Scholar
  34. 34.
    Weissleder, H., Pfannenstiel, P., Peters, P.E.: Distribution pattern of radioactive labelled Lipiodol-UF following intralymphatic application for therapy. Lymphology 9 (1976), 122PubMedGoogle Scholar
  35. 35.
    Wilhelm, A.J., Mijnhout, G.S., Franssen, E.J.F.: Radiopharmaceuticals in sentinel lymph node detection - an overview.Eur. J. Nucl. Med. 26 (1999), 36-42Google Scholar
  36. 36.
    Zilversmith, D.B.: The composition and structure of lymph chylomicrons in dog, rat and man. Journal of Clinical Investigation 44 (1965), 1610CrossRefGoogle Scholar
  37. 37.
    Zweifach, B.W., Prather, J.W.: Micromanipulation of pressure in terminal lymphatics in the mesentery. American Journal of Physiology 228 (1975), 1326PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Peter Hirnle
    • 1
  1. 1.Department of Radiation OncologyCentral Academic HospitalGermany

Personalised recommendations